Schedule 13D ownership disclosure

NOVABRIDGE BIOSCIENCES

Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) · CUSIP: 44975P103

Event date: 2026-01-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • CBC Investment I-Mab LimitedReported CIK 0001845246

    Shares: 11,784,164.00 · Class: 4.4%

  • IBC Investment Seven Limited

    Shares: 3,641,554 · Class: 1.4%

  • CBC SPVII LIMITED

    Shares: 5,574,560.00 · Class: 2.1%

  • C-Bridge II Investment Ten Limited

    Shares: 2,369,546.00 · Class: 0.9%

  • Nova Aqua Limited

    Shares: 7,129,885.00 · Class: 2.7%

  • C-Bridge Healthcare Fund II, L.P.

    Shares: 14,153,710.00 · Class: 5.3%

  • C-Bridge Healthcare Fund GP II, L.P.

    Shares: 14,153,710.00 · Class: 5.3%

  • C-Bridge Capital GP, Ltd.

    Shares: 23,369,824.00 · Class: 8.8%

  • I-Bridge Healthcare Fund, L.P.

    Shares: 9,216,114.00 · Class: 3.5%

  • I-Bridge Healthcare GP, L.P.

    Shares: 9,216,114.00 · Class: 3.5%

  • I-Bridge Capital GP, Ltd.

    Shares: 9,216,114.00 · Class: 3.5%

  • Wei Fu

    Shares: 30,499,709.00 · Class: 11.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-035559
Form type
SCHEDULE 13D/A
Filer
CBC Investment I-Mab Ltd
CIK
CIK 1845246
Filed
Feb 03, 2026
Reporting period
Jan 29, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub